ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)

ClinicalTrials.gov ID: NCT05526716

Public ClinicalTrials.gov record NCT05526716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older

Study identification

NCT ID
NCT05526716
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,080 participants

Conditions and interventions

Interventions

  • Matching Placebo for V116 Biological
  • QIV Biological
  • V116 Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2022
Primary completion
Jun 20, 2023
Completion
Jun 20, 2023
Last update posted
Oct 28, 2025

2022 – 2023

United States locations

U.S. sites
56
U.S. states
21
U.S. cities
49
Facility City State ZIP Site status
Central Phoenix Medical Clinic-Synexus Clinical Research US ( Site 0012) Phoenix Arizona 85020
Hope Clinical Research, Inc. ( Site 0070) Canoga Park California 91303
Paradigm Clinical Research Centers, Inc ( Site 0024) La Mesa California 91942
Catalina Research Institute, LLC ( Site 0067) Montclair California 91763
WR- PRI, LLC ( Site 0044) Newport Beach California 92620
Carbon Health - North Hollywood - NoHo West ( Site 0016) North Hollywood California 91606
Valley Clinical Trials, Inc. ( Site 0002) Northridge California 91325
Artemis Institute for Clinical Research ( Site 0023) San Diego California 92103
WR-MCCR, LLC ( Site 0033) San Diego California 92120
California Research Foundation ( Site 0005) San Diego California 92123
Diablo Clinical Research, Inc. ( Site 0020) Walnut Creek California 94598
Velocity Clinical Research, Hallandale Beach ( Site 0064) Hallandale Florida 33009
Indago Research & Health Center, Inc ( Site 0029) Hialeah Florida 33012
East Coast Institute for Research, LLC ( Site 0013) Jacksonville Florida 32216
Health Awareness ( Site 0034) Jupiter Florida 33458
Optimal Research ( Site 0008) Melbourne Florida 32934
Suncoast Research Group-Clinical Department ( Site 0062) Miami Florida 33135
Suncoast Research Associates ( Site 0041) Miami Florida 33173
Alpha Science Research ( Site 0042) Miami Florida 33186
Lakes Research ( Site 0063) Miami Lakes Florida 33014
Triple O Research Institute, P.A ( Site 0054) West Palm Beach Florida 33407
East Coast Institute for Research - Canton ( Site 0004) Canton Georgia 30114
Clinical Research Atlanta ( Site 0068) Stockbridge Georgia 30281
Synexus Clinical Research US, Inc. ( Site 0072) Chicago Illinois 60602
Healthcare Research Network - Chicago ( Site 0014) Flossmoor Illinois 60422
Centennial Medical Group ( Site 0035) Elkridge Maryland 21075
Healthcare Research Network - St. Louis ( Site 0011) St Louis Missouri 63042
Radiant Research ( Site 0073) St Louis Missouri 63141
Alivation Research-Primary Care ( Site 0066) Lincoln Nebraska 68526
WR-CRCN, LLC ( Site 0018) Las Vegas Nevada 89106
Axces Research ( Site 0037) Santa Fe New Mexico 87505
Smith Allergy and Asthma Specialists-Certified Research Associates ( Site 0019) Cortland New York 13045
Synexus Clinical Research US, Inc - New York ( Site 0053) New York New York 10017
Rochester Clinical Research, Inc. ( Site 0055) Rochester New York 14609
Meridian Clinical Research, LLC ( Site 0032) Vestal New York 13850
Carolina Institute for Clinical Research ( Site 0047) Fayetteville North Carolina 28303
M3 Wake Research Associates ( Site 0040) Raleigh North Carolina 27612
CTI Clinical Research Center ( Site 0071) Cincinnati Ohio 45212
Velocity Clinical Research, Medford ( Site 0060) Medford Oregon 97504
Hatboro Medical Associates / CCT Research ( Site 0065) Hatboro Pennsylvania 19040
Velocity Clinical Research, Providence ( Site 0021) East Greenwich Rhode Island 02818
Velocity Clinical Research, Anderson ( Site 0077) Anderson South Carolina 29621
Velocity Clinical Research, Columbia ( Site 0058) Columbia South Carolina 29204
Holston Medical Group-Clinical Research ( Site 0028) Bristol Tennessee 37620
Holston Medical Group-Clinical Research ( Site 0009) Kingsport Tennessee 37660
Clinical Research Associates Inc ( Site 0026) Nashville Tennessee 37203
Optimal Research ( Site 0015) Austin Texas 78705
Headlands Research - Brownsville ( Site 0069) Brownsville Texas 78526
Benchmark Research ( Site 0025) Fort Worth Texas 76135
New Horizon Medical Group ( Site 0078) Houston Texas 77042
Innovative Medical Research of Texas ( Site 0079) Houston Texas 77065
LinQ Research ( Site 0074) Pearland Texas 77584
Synexus Clinical Research US, Inc. ( Site 0001) Murray Utah 84123
Alliance for Multispecialty Research, LLC ( Site 0051) South Jordan Utah 84095
Arthritis Northwest, PLLC ( Site 0059) Spokane Washington 99204
Velocity Clinical Research, Spokane ( Site 0050) Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05526716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05526716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →